It does surprise me a little, that some people are still...

It does surprise me a little, that some people are still concerned with the "timeframe' terminology MM used in the letter to shareholders (dated the 26 September). When, just under a month later, on the 24 October, an announcement was released, reflecting the "Presentation to Investors".

in the presentation, the phrase "in the coming weeks", is used once, but, reading through it fully, there's wording, advising that the results of the trials are expected in late 2023, - in fact, the reference to late 2023 is mentioned five times in the presentation.

I'm not sure how other shareholders would define late 2023, but I would regard it as anytime between now and the 31 December 2023.

This is all in my humble opinion, of course.